These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9522840)

  • 81. Inflammation and Alzheimer's disease.
    Jones RW
    Lancet; 2001 Aug; 358(9280):436-7. PubMed ID: 11513903
    [No Abstract]   [Full Text] [Related]  

  • 82. [Current approaches to optimize treatment of dementia and Alzheimer's disease].
    Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):87-92. PubMed ID: 28635795
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Treatment for non-cognitive symptoms in Alzheimer's disease].
    Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J
    Rev Neurol; 1999 Nov 1-15; 29(9):819-24. PubMed ID: 10696656
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy.
    Zheng H; Fridkin M; Youdim MB
    Curr Drug Targets; 2012 Jul; 13(8):1089-106. PubMed ID: 22676912
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alzheimer's disease: fundamental and therapeutic aspects.
    Schorderet M
    Experientia; 1995 Feb; 51(2):99-105. PubMed ID: 7875258
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Small Molecule Natural Products and Alzheimer's Disease.
    Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
    Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography.
    Saura J; Luque JM; Cesura AM; Da Prada M; Chan-Palay V; Huber G; Löffler J; Richards JG
    Neuroscience; 1994 Sep; 62(1):15-30. PubMed ID: 7816197
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible.
    Barton D; Loprinzi C
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S121-7. PubMed ID: 12533273
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevention of Alzheimer's disease: where we stand.
    Sano M
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):392-9. PubMed ID: 12169218
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Alzheimer's disease.
    Goldberg RJ
    Compr Ther; 2007; 33(2):58-64. PubMed ID: 18004014
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Response to "Relationship between sarcopenic obesity and cognitive function in patients with mild to moderate Alzheimer's disease".
    Wei LC
    Psychogeriatrics; 2023 Nov; 23(6):1094-1095. PubMed ID: 37748760
    [No Abstract]   [Full Text] [Related]  

  • 92. Nerve growth factor gene therapy for Alzheimer's disease.
    Tuszynski MH; Thal L; U HS; Pay MM; Blesch A; Conner J; Vahlsing HL
    J Mol Neurosci; 2002; 19(1-2):207. PubMed ID: 12212782
    [No Abstract]   [Full Text] [Related]  

  • 93. Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.
    Lilienfeld S
    CNS Drug Rev; 2002; 8(2):159-76. PubMed ID: 12177686
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Recent advances in the treatment of Alzheimer's.
    Richter RW; Farlow MR
    J Okla State Med Assoc; 1998 Nov; 91(8):431-7. PubMed ID: 9828525
    [No Abstract]   [Full Text] [Related]  

  • 95. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development.
    Cutler NR; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):27-57. PubMed ID: 11263756
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Progress in the management of Alzheimer's disease.
    Smith AL; Whitehouse PJ
    Hosp Pract (1995); 1998 Mar; 33(3):151-4, 157-66. PubMed ID: 9522840
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.